Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2021

Upgrades

According to Wells Fargo, the prior rating for Douglas Emmett Inc DEI was changed from Equal-Weight to Overweight. In the third quarter, Douglas Emmett showed an EPS of $0.48, compared to $0.40 from the year-ago quarter. At the moment, the stock has a 52-week-high of $36.97 and a 52-week-low of $26.45. Douglas Emmett closed at $33.00 at the end of the last trading period.
According to William Blair, the prior rating for Ionis Pharmaceuticals Inc IONS was changed from Market Perform to Outperform. Ionis Pharmaceuticals earned $0.34 in the third quarter, compared to $0.22 in the year-ago quarter. At the moment, the stock has a 52-week-high of $64.37 and a 52-week-low of $25.04. Ionis Pharmaceuticals closed at $30.17 at the end of the last trading period.
According to UBS, the prior rating for General Dynamics Corp GD was changed from Neutral to Buy. General Dynamics earned $3.07 in the third quarter, compared to $2.90 in the year-ago quarter. The current stock performance of General Dynamics shows a 52-week-high of $210.21 and a 52-week-low of $144.50. Moreover, at the end of the last trading period, the closing price was at $203.49.
JP Morgan upgraded the previous rating for SS&C Technologies Holdings Inc SSNC from Neutral to Overweight. SS&C Technologies Hldgs earned $1.32 in the third quarter, compared to $1.10 in the year-ago quarter. The current stock performance of SS&C Technologies Hldgs shows a 52-week-high of $80.55 and a 52-week-low of $62.51. Moreover, at the end of the last trading period, the closing price was at $78.16.
Raymond James upgraded the previous rating for Shenandoah Telecommunications Co SHEN from Market Perform to Outperform. In the third quarter, Shenandoah showed an EPS of $0.13, compared to $0.03 from the year-ago quarter. The current stock performance of Shenandoah shows a 52-week-high of $61.53 and a 52-week-low of $24.44. Moreover, at the end of the last trading period, the closing price was at $25.36.
For Avalara Inc AVLR, JP Morgan upgraded the previous rating of Neutral to Overweight. Avalara earned $0.03 in the third quarter, compared to $0.02 in the year-ago quarter. The stock has a 52-week-high of $191.67 and a 52-week-low of $117.33. At the end of the last trading period, Avalara closed at $142.94.
According to Morgan Stanley, the prior rating for Melco Resorts and Entertainment Ltd MLCO was changed from Equal-Weight to Overweight. Melco Resorts and Enter earned $0.43 in the third quarter, compared to $0.70 in the year-ago quarter. The current stock performance of Melco Resorts and Enter shows a 52-week-high of $23.65 and a 52-week-low of $9.09. Moreover, at the end of the last trading period, the closing price was at $9.77.
According to JP Morgan, the prior rating for NOV Inc NOV was changed from Neutral to Overweight. NOV earned $0.09 in the third quarter, compared to $0.02 in the year-ago quarter. The stock has a 52-week-high of $18.02 and a 52-week-low of $11.46. At the end of the last trading period, NOV closed at $13.07.
B of A Securities upgraded the previous rating for Apple Inc AAPL from Neutral to Buy. For the fourth quarter, Apple had an EPS of $1.24, compared to year-ago quarter EPS of $0.73. The stock has a 52-week-high of $182.13 and a 52-week-low of $116.21. At the end of the last trading period, Apple closed at $175.74.
For Pros Holdings Inc PRO, JP Morgan upgraded the previous rating of Underweight to Neutral. In the third quarter, Pros Holdings showed an EPS of $0.13, compared to $0.15 from the year-ago quarter. The current stock performance of Pros Holdings shows a 52-week-high of $51.83 and a 52-week-low of $23.08. Moreover, at the end of the last trading period, the closing price was at $33.63.
For Beyond Meat Inc BYND, Piper Sandler upgraded the previous rating of Underweight to Neutral. In the third quarter, Beyond Meat showed an EPS of $0.87, compared to $0.28 from the year-ago quarter. At the moment, the stock has a 52-week-high of $221.00 and a 52-week-low of $62.06. Beyond Meat closed at $63.42 at the end of the last trading period.
For Unity Software Inc U, Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. For the third quarter, Unity Software had an EPS of $0.06, compared to year-ago quarter EPS of $0.09. At the moment, the stock has a 52-week-high of $210.00 and a 52-week-low of $76.00. Unity Software closed at $139.75 at the end of the last trading period.
For AppLovin Corp APP, Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. At the moment, the stock has a 52-week-high of $116.09 and a 52-week-low of $49.41. AppLovin closed at $88.85 at the end of the last trading period.
Wolfe Research upgraded the previous rating for AMETEK Inc AME from Peer Perform to Outperform. In the third quarter, AMETEK showed an EPS of $1.26, compared to $1.01 from the year-ago quarter. At the moment, the stock has a 52-week-high of $143.55 and a 52-week-low of $106.96. AMETEK closed at $142.50 at the end of the last trading period.
According to JP Morgan, the prior rating for Model N Inc MODN was changed from Neutral to Overweight. In the fourth quarter, Model N showed an EPS of $0.18, compared to $0.14 from the year-ago quarter. The stock has a 52-week-high of $48.20 and a 52-week-low of $25.83. At the end of the last trading period, Model N closed at $28.90.
Goldman Sachs upgraded the previous rating for Academy Sports and Outdoors Inc ASO from Neutral to Buy. In the third quarter, Academy Sports showed an EPS of $1.75, compared to $0.91 from the year-ago quarter. The current stock performance of Academy Sports shows a 52-week-high of $51.08 and a 52-week-low of $17.20. Moreover, at the end of the last trading period, the closing price was at $42.52.
For Capri Holdings Ltd CPRI, Goldman Sachs upgraded the previous rating of Neutral to Buy. In the second quarter, Capri Holdings showed an EPS of $1.53, compared to $0.90 from the year-ago quarter. The stock has a 52-week-high of $69.26 and a 52-week-low of $37.95. At the end of the last trading period, Capri Holdings closed at $62.49.

See all analyst ratings upgrades.

Downgrades

For IGM Biosciences Inc IGMS, Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. In the third quarter, IGM Biosciences showed an EPS of $1.32, compared to $0.66 from the year-ago quarter. At the moment, the stock has a 52-week-high of $127.11 and a 52-week-low of $25.45. IGM Biosciences closed at $29.25 at the end of the last trading period.
UBS downgraded the previous rating for Charter Communications Inc CHTR from Buy to Neutral. For the third quarter, Charter Communications had an EPS of $6.50, compared to year-ago quarter EPS of $3.90. At the moment, the stock has a 52-week-high of $825.62 and a 52-week-low of $585.45. Charter Communications closed at $605.55 at the end of the last trading period.
According to Citigroup, the prior rating for Arena Pharmaceuticals Inc ARNA was changed from Buy to Neutral. In the third quarter, Arena Pharmaceuticals showed an EPS of $3.21, compared to $1.69 from the year-ago quarter. The stock has a 52-week-high of $94.08 and a 52-week-low of $45.50. At the end of the last trading period, Arena Pharmaceuticals closed at $90.08.
According to Macquarie, the prior rating for Lions Gate Entertainment Corp LGF was changed from Outperform to Neutral. Lions Gate Enter earned $0.15 in the second quarter, compared to $0.33 in the year-ago quarter.
JP Morgan downgraded the previous rating for CCC Intelligent Solutions Holdings Inc CCCS from Neutral to Underweight. CCC Intelligent Solutions earned $0.05 in the third quarter, compared to $0.01 in the year-ago quarter.
Wolfe Research downgraded the previous rating for Southwestern Energy Co SWN from Outperform to Peer Perform. For the third quarter, Southwestern Energy had an EPS of $0.24, compared to year-ago quarter EPS of $0.08. At the moment, the stock has a 52-week-high of $5.96 and a 52-week-low of $2.92. Southwestern Energy closed at $5.00 at the end of the last trading period.
For Cadence Design Systems Inc CDNS, JP Morgan downgraded the previous rating of Overweight to Neutral. Cadence Design Systems earned $0.80 in the third quarter, compared to $0.70 in the year-ago quarter. The current stock performance of Cadence Design Systems shows a 52-week-high of $190.09 and a 52-week-low of $116.66. Moreover, at the end of the last trading period, the closing price was at $184.13.
UBS downgraded the previous rating for L3Harris Technologies Inc LHX from Buy to Neutral. In the third quarter, L3Harris Technologies showed an EPS of $3.21, compared to $2.84 from the year-ago quarter. The current stock performance of L3Harris Technologies shows a 52-week-high of $246.08 and a 52-week-low of $168.70. Moreover, at the end of the last trading period, the closing price was at $217.94.
Evercore ISI Group downgraded the previous rating for Dell Technologies Inc DELL from Outperform to In-Line. In the third quarter, Dell Technologies showed an EPS of $2.37, compared to $2.03 from the year-ago quarter. The current stock performance of Dell Technologies shows a 52-week-high of $115.00 and a 52-week-low of $53.01. Moreover, at the end of the last trading period, the closing price was at $55.72.
For Comcast Corp CMCSA, Macquarie downgraded the previous rating of Outperform to Neutral. Comcast earned $0.87 in the third quarter, compared to $0.65 in the year-ago quarter. The current stock performance of Comcast shows a 52-week-high of $61.80 and a 52-week-low of $47.45. Moreover, at the end of the last trading period, the closing price was at $47.71.
For Arena Pharmaceuticals Inc ARNA, JMP Securities downgraded the previous rating of Market Outperform to Market Perform. Arena Pharmaceuticals earned $3.21 in the third quarter, compared to $1.69 in the year-ago quarter. At the moment, the stock has a 52-week-high of $94.08 and a 52-week-low of $45.50. Arena Pharmaceuticals closed at $90.08 at the end of the last trading period.
Daiwa Capital downgraded the previous rating for General Motors Co GM from Outperform to Neutral. In the third quarter, General Motors showed an EPS of $1.52, compared to $2.83 from the year-ago quarter. The current stock performance of General Motors shows a 52-week-high of $65.18 and a 52-week-low of $40.04. Moreover, at the end of the last trading period, the closing price was at $59.13.
SVB Leerink downgraded the previous rating for Arena Pharmaceuticals Inc ARNA from Outperform to Market Perform. Arena Pharmaceuticals earned $3.21 in the third quarter, compared to $1.69 in the year-ago quarter. The stock has a 52-week-high of $94.08 and a 52-week-low of $45.50. At the end of the last trading period, Arena Pharmaceuticals closed at $90.08.
RBC Capital downgraded the previous rating for Arena Pharmaceuticals Inc ARNA from Outperform to Sector Perform. For the third quarter, Arena Pharmaceuticals had an EPS of $3.21, compared to year-ago quarter EPS of $1.69. The current stock performance of Arena Pharmaceuticals shows a 52-week-high of $94.08 and a 52-week-low of $45.50. Moreover, at the end of the last trading period, the closing price was at $90.08.
JP Morgan downgraded the previous rating for Adobe Inc ADBE from Overweight to Neutral. Adobe earned $3.11 in the third quarter, compared to $2.57 in the year-ago quarter. The current stock performance of Adobe shows a 52-week-high of $699.54 and a 52-week-low of $420.78. Moreover, at the end of the last trading period, the closing price was at $658.30.
JP Morgan downgraded the previous rating for Akamai Technologies Inc AKAM from Neutral to Underweight. Akamai Technologies earned $1.45 in the third quarter, compared to $1.31 in the year-ago quarter. The stock has a 52-week-high of $124.91 and a 52-week-low of $92.64. At the end of the last trading period, Akamai Technologies closed at $115.41.
For Amdocs Ltd DOX, JP Morgan downgraded the previous rating of Overweight to Neutral. In the fourth quarter, Amdocs showed an EPS of $1.16, compared to $1.23 from the year-ago quarter. The current stock performance of Amdocs shows a 52-week-high of $82.38 and a 52-week-low of $66.02. Moreover, at the end of the last trading period, the closing price was at $72.70.
For Blucora Inc BCOR, JP Morgan downgraded the previous rating of Overweight to Neutral. In the third quarter, Blucora showed an EPS of $0.26, compared to $0.31 from the year-ago quarter. The current stock performance of Blucora shows a 52-week-high of $18.83 and a 52-week-low of $12.95. Moreover, at the end of the last trading period, the closing price was at $17.14.
According to JP Morgan, the prior rating for Cloudflare Inc NET was changed from Neutral to Underweight. Cloudflare earned $0.00 in the third quarter, compared to $0.02 in the year-ago quarter. The current stock performance of Cloudflare shows a 52-week-high of $221.64 and a 52-week-low of $60.96. Moreover, at the end of the last trading period, the closing price was at $145.03.
For Datadog Inc DDOG, JP Morgan downgraded the previous rating of Neutral to Underweight. For the third quarter, Datadog had an EPS of $0.13, compared to year-ago quarter EPS of $0.05. The stock has a 52-week-high of $199.68 and a 52-week-low of $69.73. At the end of the last trading period, Datadog closed at $172.03.
JP Morgan downgraded the previous rating for PTC Inc PTC from Overweight to Neutral. In the fourth quarter, PTC showed an EPS of $1.10, compared to $0.78 from the year-ago quarter. The stock has a 52-week-high of $153.73 and a 52-week-low of $105.49. At the end of the last trading period, PTC closed at $122.52.
According to JP Morgan, the prior rating for Zscaler Inc ZS was changed from Neutral to Underweight. For the first quarter, Zscaler had an EPS of $0.14, compared to year-ago quarter EPS of $0.14. The current stock performance of Zscaler shows a 52-week-high of $376.11 and a 52-week-low of $157.03. Moreover, at the end of the last trading period, the closing price was at $308.54.
For Arena Pharmaceuticals Inc ARNA, Jefferies downgraded the previous rating of Buy to Hold. Arena Pharmaceuticals earned $3.21 in the third quarter, compared to $1.69 in the year-ago quarter. At the moment, the stock has a 52-week-high of $94.08 and a 52-week-low of $45.50. Arena Pharmaceuticals closed at $90.08 at the end of the last trading period.
According to Goldman Sachs, the prior rating for Big Lots Inc BIG was changed from Neutral to Sell. Big Lots earned $0.14 in the third quarter, compared to $0.76 in the year-ago quarter. At the moment, the stock has a 52-week-high of $73.23 and a 52-week-low of $41.76. Big Lots closed at $43.97 at the end of the last trading period.
Goldman Sachs downgraded the previous rating for Ollie's Bargain Outlet Holdings Inc OLLI from Neutral to Sell. For the third quarter, Ollie's Bargain Outlet had an EPS of $0.34, compared to year-ago quarter EPS of $0.65. The stock has a 52-week-high of $123.52 and a 52-week-low of $48.99. At the end of the last trading period, Ollie's Bargain Outlet closed at $50.47.
For Ralph Lauren Corp RL, Goldman Sachs downgraded the previous rating of Buy to Sell. For the second quarter, Ralph Lauren had an EPS of $2.62, compared to year-ago quarter EPS of $1.44. The current stock performance of Ralph Lauren shows a 52-week-high of $142.06 and a 52-week-low of $97.72. Moreover, at the end of the last trading period, the closing price was at $120.08.
For Doximity Inc DOCS, JP Morgan downgraded the previous rating of Neutral to Underweight. At the moment, the stock has a 52-week-high of $107.79 and a 52-week-low of $41.17. Doximity closed at $55.68 at the end of the last trading period.
Wolfe Research downgraded the previous rating for Vertiv Holdings Co VRT from Outperform to Peer Perform. In the third quarter, Vertiv Holdings showed an EPS of $0.20, compared to $0.32 from the year-ago quarter. The stock has a 52-week-high of $28.80 and a 52-week-low of $17.88. At the end of the last trading period, Vertiv Holdings closed at $25.45.

See all analyst ratings downgrades.

Initiations

UBS initiated coverage on United Natural Foods Inc UNFI with a Buy rating. The price target for United Natural Foods is set to $64.00. United Natural Foods earned $0.97 in the first quarter, compared to $0.51 in the year-ago quarter. At the moment, the stock has a 52-week-high of $57.89 and a 52-week-low of $14.55. United Natural Foods closed at $51.05 at the end of the last trading period.
With a Buy rating, UBS initiated coverage on Blue Owl Capital Inc OWL. The price target seems to have been set at $18.00 for Blue Owl Capital. At the moment, the stock has a 52-week-high of $17.89 and a 52-week-low of $9.68. Blue Owl Capital closed at $14.80 at the end of the last trading period.
UBS initiated coverage on Ollie's Bargain Outlet Holdings Inc OLLI with a Neutral rating. The price target for Ollie's Bargain Outlet is set to $55.00. Ollie's Bargain Outlet earned $0.34 in the third quarter, compared to $0.65 in the year-ago quarter. At the moment, the stock has a 52-week-high of $123.52 and a 52-week-low of $48.99. Ollie's Bargain Outlet closed at $50.47 at the end of the last trading period.
Craig-Hallum initiated coverage on Markforged Holding Corp MKFG with a Buy rating. The price target for Markforged Holding is set to $10.00. In the third quarter, Markforged Holding showed an EPS of $0.10, compared to $0.10 from the year-ago quarter.
UBS initiated coverage on Albertsons Companies Inc ACI with a Neutral rating. The price target for Albertsons Companies is set to $33.00. In the second quarter, Albertsons Companies showed an EPS of $0.64, compared to $0.60 from the year-ago quarter. At the moment, the stock has a 52-week-high of $37.85 and a 52-week-low of $14.83. Albertsons Companies closed at $31.32 at the end of the last trading period.
With a Buy rating, B. Riley Securities initiated coverage on Charah Solutions Inc CHRA. The price target seems to have been set at $7.50 for Charah Solns. In the third quarter, Charah Solns showed an EPS of $0.08, compared to $0.08 from the year-ago quarter. The current stock performance of Charah Solns shows a 52-week-high of $6.63 and a 52-week-low of $2.56. Moreover, at the end of the last trading period, the closing price was at $4.50.
With a Buy rating, Canaccord Genuity initiated coverage on SomaLogic Inc SLGC. The price target seems to have been set at $19.00 for SomaLogic.
With an Overweight rating, Stephens & Co. initiated coverage on FinWise Bancorp FINW. The price target seems to have been set at $22.50 for FinWise.
With an Underweight rating, Morgan Stanley initiated coverage on Frontier Communications Parent Inc FYBR. The price target seems to have been set at $24.00 for Frontier Communications. The current stock performance of Frontier Communications shows a 52-week-high of $35.15 and a 52-week-low of $23.24. Moreover, at the end of the last trading period, the closing price was at $33.78.
Citigroup initiated coverage on Iris Energy Ltd IREN with a Buy rating. The price target for Iris Energy is set to $18.00.
With a Buy rating, EF Hutton initiated coverage on Pasithea Therapeutics Corp KTTA. The price target seems to have been set at $3.25 for Pasithea Therapeutics.
Wolfe Research initiated coverage on Denbury Inc DEN with an Outperform rating. The price target for Denbury is set to $117.00. Denbury earned $0.74 in the third quarter, compared to $0.05 in the year-ago quarter. At the moment, the stock has a 52-week-high of $91.30 and a 52-week-low of $24.01. Denbury closed at $79.65 at the end of the last trading period.
With an Overweight rating, Cantor Fitzgerald initiated coverage on Volta Inc VLTA. The price target seems to have been set at $13.00 for Volta.
Benchmark initiated coverage on Highland Transcend Partners I Corp HTPA with a Buy rating. The price target for Highland Transcend is set to $18.00. The stock has a 52-week-high of $10.97 and a 52-week-low of $9.61. At the end of the last trading period, Highland Transcend closed at $9.91.
Barclays initiated coverage on Braze Inc BRZE with an Overweight rating. The price target for Braze is set to $95.00.
Goldman Sachs initiated coverage on Alignment Healthcare Inc ALHC with a Buy rating. The price target for Alignment Healthcare is set to $20.00. The current stock performance of Alignment Healthcare shows a 52-week-high of $28.59 and a 52-week-low of $12.92. Moreover, at the end of the last trading period, the closing price was at $13.60.
With a Buy rating, Goldman Sachs initiated coverage on Molina Healthcare Inc MOH. The price target seems to have been set at $335.00 for Molina Healthcare. Molina Healthcare earned $2.83 in the third quarter, compared to $3.36 in the year-ago quarter. The stock has a 52-week-high of $316.04 and a 52-week-low of $196.08. At the end of the last trading period, Molina Healthcare closed at $300.94.
With a Buy rating, Goldman Sachs initiated coverage on CVS Health Corp CVS. The price target seems to have been set at $121.00 for CVS Health. For the third quarter, CVS Health had an EPS of $1.97, compared to year-ago quarter EPS of $1.66. The stock has a 52-week-high of $99.33 and a 52-week-low of $67.06. At the end of the last trading period, CVS Health closed at $98.90.
Goldman Sachs initiated coverage on UnitedHealth Group Inc UNH with a Buy rating. The price target for UnitedHealth Group is set to $535.00. In the third quarter, UnitedHealth Group showed an EPS of $4.52, compared to $3.51 from the year-ago quarter. At the moment, the stock has a 52-week-high of $480.26 and a 52-week-low of $320.35. UnitedHealth Group closed at $478.14 at the end of the last trading period.
Goldman Sachs initiated coverage on Bath & Body Works Inc BBWI with a Buy rating. The price target for Bath & Body Works is set to $93.00. Bath & Body Works earned $0.92 in the third quarter, compared to $1.13 in the year-ago quarter.
Needham initiated coverage on Datto Holding Corp MSP with a Buy rating. The price target for Datto Holding is set to $29.00. In the third quarter, Datto Holding showed an EPS of $0.16, compared to $0.18 from the year-ago quarter. The current stock performance of Datto Holding shows a 52-week-high of $30.42 and a 52-week-low of $21.98. Moreover, at the end of the last trading period, the closing price was at $24.99.
With a Neutral rating, Goldman Sachs initiated coverage on Callaway Golf Co ELY. The price target seems to have been set at $29.00 for Callaway Golf. For the third quarter, Callaway Golf had an EPS of $0.14, compared to year-ago quarter EPS of $0.60. The stock has a 52-week-high of $37.75 and a 52-week-low of $22.47. At the end of the last trading period, Callaway Golf closed at $27.58.
Piper Sandler initiated coverage on FinWise Bancorp FINW with an Overweight rating. The price target for FinWise is set to $15.50.
With an Overweight rating, Morgan Stanley initiated coverage on ironSource Ltd IS. The price target seems to have been set at $10.50 for ironSource. The stock has a 52-week-high of $13.14 and a 52-week-low of $7.56. At the end of the last trading period, ironSource closed at $7.75.
With an Outperform rating, Cowen & Co. initiated coverage on Luminar Technologies Inc LAZR. The price target seems to have been set at $22.00 for Luminar Technologies. At the moment, the stock has a 52-week-high of $40.98 and a 52-week-low of $13.45. Luminar Technologies closed at $14.67 at the end of the last trading period.
With a Neutral rating, B of A Securities initiated coverage on Navitas Semiconductor Corp NVTS. The price target seems to have been set at $20.00 for Navitas Semiconductor. For the third quarter, Navitas Semiconductor had an EPS of $0.39, compared to year-ago quarter EPS of $0.27.
Goldman Sachs initiated coverage on Bright Health Group Inc BHG with a Neutral rating. The price target for Bright Health Gr is set to $5.00. For the third quarter, Bright Health Gr had an EPS of $0.48, compared to year-ago quarter EPS of $0.43. At the moment, the stock has a 52-week-high of $17.93 and a 52-week-low of $3.07. Bright Health Gr closed at $4.10 at the end of the last trading period.
Goldman Sachs initiated coverage on Cigna Corp CI with a Neutral rating. The price target for Cigna is set to $233.00. In the third quarter, Cigna showed an EPS of $5.73, compared to $4.41 from the year-ago quarter. The stock has a 52-week-high of $272.81 and a 52-week-low of $190.88. At the end of the last trading period, Cigna closed at $215.15.
Goldman Sachs initiated coverage on Centene Corp CNC with a Neutral rating. The price target for Centene is set to $83.00. In the third quarter, Centene showed an EPS of $1.26, compared to $1.26 from the year-ago quarter. The stock has a 52-week-high of $79.74 and a 52-week-low of $57.16. At the end of the last trading period, Centene closed at $78.15.
Goldman Sachs initiated coverage on Humana Inc HUM with a Neutral rating. The price target for Humana is set to $472.00. In the third quarter, Humana showed an EPS of $4.83, compared to $3.08 from the year-ago quarter. At the moment, the stock has a 52-week-high of $475.44 and a 52-week-low of $370.22. Humana closed at $464.37 at the end of the last trading period.
With a Sell rating, Goldman Sachs initiated coverage on Oscar Health Inc OSCR. The price target seems to have been set at $6.50 for Oscar Health. The current stock performance of Oscar Health shows a 52-week-high of $37.00 and a 52-week-low of $8.24. Moreover, at the end of the last trading period, the closing price was at $10.46.
Bernstein initiated coverage on Hyatt Hotels Corp H with an Outperform rating. The price target for Hyatt Hotels is set to $105.00. In the third quarter, Hyatt Hotels showed an EPS of $2.31, compared to $1.48 from the year-ago quarter. The current stock performance of Hyatt Hotels shows a 52-week-high of $94.92 and a 52-week-low of $65.44. Moreover, at the end of the last trading period, the closing price was at $82.63.
Needham initiated coverage on Clearfield Inc CLFD with a Buy rating. The price target for Clearfield is set to $92.00. For the fourth quarter, Clearfield had an EPS of $0.53, compared to year-ago quarter EPS of $0.22. At the moment, the stock has a 52-week-high of $72.00 and a 52-week-low of $23.60. Clearfield closed at $63.21 at the end of the last trading period.
With an Overweight rating, Keybanc initiated coverage on Entegris Inc ENTG. The price target seems to have been set at $183.00 for Entegris. For the third quarter, Entegris had an EPS of $0.92, compared to year-ago quarter EPS of $0.67. At the moment, the stock has a 52-week-high of $158.00 and a 52-week-low of $91.78. Entegris closed at $142.28 at the end of the last trading period.